Thanks, brief section on CHM.. key take out from that snippet is that Paul Hopper just confirmed that they plan to finish up the phase 1 trial in 2022... that means finish off the cohort 3 which they just commenced and cohort 4. So they may be in the pivotal phase 2 trial in 2023... and that is where partnerships/take-overs come into play... assuming the data from the phase 1 trial is strong of course
Exciting times... 2022 is going to be a big year for CHM.. but 2023 probably even bigger!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $6.217K | 1.554M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 9210636 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18629873 | 23 |
View Market Depth
| Last trade - 11.35am 25/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |